Cardiovascular mortality · patients without heart failure
Natriuretic peptide‐guided treatment showed no clear difference in cardiovascular mortality compared with standard care (low certainty).
1 finding from 1 review
Cardiovascular hospitalisation (as defined by trialists) · patients without heart failure
Natriuretic peptide‐guided treatment probably leads to lower cardiovascular hospitalisation (as defined by trialists) compared with standard care (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients without heart failure
Natriuretic peptide‐guided treatment showed no clear difference in all‐cause mortality compared with standard care (low certainty).
1 finding from 1 review
Hospitalisation (any cause) · patients without heart failure
Natriuretic peptide‐guided treatment probably leads to lower all‐cause hospitalisation (all occurrences) compared with standard care (moderate certainty).
1 finding from 1 review
Ventricular dysfunction (as defined by trialists) · patients without heart failure
Natriuretic peptide‐guided treatment leads to lower ventricular dysfunction (as defined by trialists) compared with standard care (high certainty).
1 finding from 1 review
Change in NP level at the end of · patients without heart failure
1 finding from 1 review
All‐cause mortality · patients with heart failure
Does treatment guided by serial BNP or NT‐proBNP monitoring improve… showed no clear difference in all‐cause mortality compared with treatment guided by clinical assessment alone? (low certainty).
1 finding from 1 review
Heart failure mortality · patients with heart failure
Does treatment guided by serial BNP or NT‐proBNP monitoring improve… showed no clear difference in heart failure mortality compared with treatment guided by clinical assessment alone? (low certainty).
1 finding from 1 review
Heart failure hospitalisation (RR) · patients with heart failure
Does treatment guided by serial BNP or NT‐proBNP monitoring improve… may leads to lower heart failure admissions compared with treatment guided by clinical assessment alone? (low certainty).
1 finding from 1 review
Hospital admissions · patients with heart failure
Does treatment guided by serial BNP or NT‐proBNP monitoring improve… showed no clear difference in all‐cause admissions compared with treatment guided by clinical assessment alone? (low certainty).
1 finding from 1 review
Adverse events · patients with heart failure
1 finding from 1 review
Costs · patients with heart failure
1 finding from 1 review
Quality of life (MLHFQ): from 0 to 105 · patients with heart failure
1 finding from 1 review